Current status of gene therapy in melanoma treatment
被引:4
|
作者:
Wang, Yonglu
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Tech Univ, Coll Pharm, Nanjing, Peoples R China
Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, CanadaNanjing Tech Univ, Coll Pharm, Nanjing, Peoples R China
Wang, Yonglu
[1
,2
]
You, Wei
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Tech Univ, Coll Pharm, Nanjing, Peoples R ChinaNanjing Tech Univ, Coll Pharm, Nanjing, Peoples R China
You, Wei
[1
]
Li, Xueming
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Bestform Pharmaceut Technol Co Ltd, Nanjing, Peoples R China
Nanjing Tech Univ, Postgrad Dept, Nanjing, Peoples R ChinaNanjing Tech Univ, Coll Pharm, Nanjing, Peoples R China
Li, Xueming
[3
,4
]
机构:
[1] Nanjing Tech Univ, Coll Pharm, Nanjing, Peoples R China
Melanoma is the deadliest type of skin cancer and which has a high ability of metastasis. Surgery is an effective method to treat I or II stage melanoma patients. However, there are few treatment options for metastatic melanoma. Gene therapy is one of the attractive options and is considered as the future direction for treating melanoma. This review mainly discusses the properties and challenges of the various gene therapies in melanoma, especially the delivery systems and gene targeting.
机构:
Virginia Commonwealth Univ, Inst Mol Med VIMM, Massey Canc Ctr, Dept Human & Mol Genet, Richmond, VA 23298 USAVirginia Commonwealth Univ, Inst Mol Med VIMM, Massey Canc Ctr, Dept Human & Mol Genet, Richmond, VA 23298 USA